Comparison of kidney and hepatic outcomes among sodium-glucose cotransporter-2 inhibitors: a retrospective study using multiple propensity scores

• Main Authors: Kazuya Hiura (Author), Chinami Suzuki (Author), Junichi Kubo (Author), Haruka Goto (Author), Shigo Takatori (Author), Kiyomi Ishida (Author), Yuki Tanaka (Author), Akifumi Mizutani (Author), Yuki Yamashita (Author), Chiho Kurumazuka (Author), Akihiko Takagi (Author), Ryu Kobayashi (Author), Akio Shibanami (Author)
• Format: Book
• Published: BMC, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been reported to have effects beyond lowering blood glucose levels, with certain SGLT2i expanding their indications to chronic kidney disease and chronic heart failure. We focused on the hepatoprotective and renoprotective e...